Maaike P.G. Vreeswijk

6.1k citations

50 papers · 1.7k indexed · h-index 22

Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
Genetics top 5%
- BRCA gene mutations in cancer 25
- Genomics and Rare Diseases 6
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 6
Oncology top 5%
- PARP inhibition in cancer therapy 12
Molecular Biology top 10%
- DNA Repair Mechanisms 25
- CRISPR and Genetic Engineering 17
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 7

Co-authors: Harry Vrieling Peter Devilee Christi J. van Asperen Jan H.J. Hoeijmakers A.A. van Zeeland Dik C. van Gent Carolien H. M. van Deurzen Roland Kanaar
Cited by: Cancer Research Genetics Reproductive Medicine
Journals: Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Maaike P.G. Vreeswijk

50 papers receiving 1.7k citations

Peers

Countries citing papers authored by Maaike P.G. Vreeswijk

Since Specialization

Citations

This map shows the geographic impact of Maaike P.G. Vreeswijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maaike P.G. Vreeswijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maaike P.G. Vreeswijk more than expected).

Fields of papers citing papers by Maaike P.G. Vreeswijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maaike P.G. Vreeswijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maaike P.G. Vreeswijk. The network helps show where Maaike P.G. Vreeswijk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maaike P.G. Vreeswijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maaike P.G. Vreeswijk Line = papers co-authored together Maaike P.G. Vreeswijk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants Clinical Chemistry ·Lara Sanoguera‐Miralles,Alberto Valenzuela‐Palomo,Elena Bueno‐Martínez,Ada Esteban‐Sánchez,Víctor Lorca,Inés Llinares‐Burguet,Alicia García‐Álvarez,Pedro Pérez‐Segura,Mar Infante,Douglas F. Easton,Peter Devilee,Maaike P.G. Vreeswijk,Miguel de la Hoya,Eladio A. Velasco	2023	5
2	RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test The Journal of Pathology Clinical Research ·Claire J.H. Kramer,Alba Llop‐Guevara,Elisa Yaniz‐Galende,Benedetta Pellegrino,Natalja T. ter Haar,Andrea Herencia‐Ropero,Nicoletta Campanini,Antonino Musolino,Tjalling Bosse,Alexandra Léary,Violeta Serra,Maaike P.G. Vreeswijk	2023	3
3	Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue Breast Cancer Research and Treatment ·Lise M. van Wijk,Sylvia Vermeulen,Natalja T. ter Haar,Claire J.H. Kramer,Diantha Terlouw,Harry Vrieling,Danielle Cohen,Maaike P.G. Vreeswijk	2023	2
4	CHEK2 variants: linking functional impact to cancer risk Trends in cancer ·Rick A.C.M. Boonen,Maaike P.G. Vreeswijk,Haico van Attikum	2022	21
5	Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk Cancer Research ·Rick A.C.M. Boonen,Wouter W. Wiegant,Nandi Celosse,Bas Vroling,Stephan Heijl,Zsofia Kote‐Jarai,Martina Mijušković,Simona Cristea,Nienke Solleveld‐Westerink,Tom van Wezel,Niko Beerenwinkel,Rosalind A. Eeles,Peter Devilee,Maaike P.G. Vreeswijk,Giancarlo Marra,Haico van Attikum	2021	33
6	Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays Clinical Cancer Research ·Peter Bouwman,Ingrid van der Heijden,Hanneke van der Gulden,Roebi de Bruijn,Merel E. Braspenning,Setareh Moghadasi,Lodewyk F.A. Wessels,(unknown),Maaike P.G. Vreeswijk,Jos Jonkers	2020	20
7	Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation Journal of Medical Genetics ·Álvaro N.A. Monteiro,Peter Bouwman,Arne Nedergaard Kousholt,Diana Eccles,Gaël A. Millot,Jean‐Yves Masson,Marjanka K. Schmidt,Shyam K. Sharan,Ralph Scully,Lisa Wiesmüller,Fergus J. Couch,Maaike P.G. Vreeswijk	2020	32
8	Germline BRCA -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity Clinical Cancer Research ·Marthe M. de Jonge,Lauren L. Ritterhouse,Cor D. de Kroon,Maaike P.G. Vreeswijk,Jeremy P. Segal,Rutika Puranik,Harry Hollema,Matti A. Rookus,Christi J. van Asperen,Flora E. van Leeuwen,Vincent T.H.B.M. Smit,Brooke E. Howitt,Tjalling Bosse	2019	34
9	Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2 Nature Communications ·Rick A.C.M. Boonen,Amélie Rodrigue,Chantal Stoepker,Wouter W. Wiegant,Bas Vroling,Milan Sharma,Magdalena B. Rother,Nandi Celosse,Maaike P.G. Vreeswijk,Fergus J. Couch,Jacques Simard,Peter Devilee,Jean‐Yves Masson,Haico van Attikum	2019	40
10	Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas Clinical Cancer Research ·Marthe M. de Jonge,Aurélie Auguste,Lise M. van Wijk,Philip C. Schouten,Matty Meijers,Natalja T. ter Haar,Vincent T.H.B.M. Smit,Remi A. Nout,Mark A. Glaire,David N. Church,Harry Vrieling,Bastien Job,Yannick Boursin,Cor D. de Kroon,Étienne Rouleau,Alexandra Léary,Maaike P.G. Vreeswijk,Tjalling Bosse	2018	119
11	Performance of BRCA1/2 mutation prediction models in male breast cancer patients Clinical Genetics ·Setareh Moghadasi,V. Grundeken,Luc Janssen,N Dijkstra,Mar Rodríguez‐Girondo,Wendy A.G. van Zelst–Stams,Jan C. Oosterwijk,Margreet G.E.M. Ausems,Reinhard Oldenburg,Muriel A. Adank,Eveline W Blom,Mariëlle Ruijs,Theo A.M. van Os,Carolien H. M. van Deurzen,J.W.M. Martens,Caroline P. Schröder,Juul Wijnen,Maaike P.G. Vreeswijk,Christi J. van Asperen	2017	3
12	Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report European Journal of Cancer ·Marthe M. de Jonge,Antien L. Mooyaart,Maaike P.G. Vreeswijk,Cor D. de Kroon,Tom van Wezel,Christi J. van Asperen,Vincent T.H.B.M. Smit,Olaf M. Dekkers,Tjalling Bosse	2017	41
13	The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study BMC Cancer ·Stefanie de Groot,Maaike P.G. Vreeswijk,Marij J.P. Welters,Gido Gravesteijn,J.J.W.A. Boei,Anouk Jochems,Daniel Houtsma,Hein Putter,Jacobus JM van der Hoeven,J.W.R. Nortier,Hanno Pijl,Judith R. Kroep	2015	173
14	Functional Ex Vivo Assay to Select Homologous Recombination–Deficient Breast Tumors for PARP Inhibitor Treatment Clinical Cancer Research ·Kishan A.T. Naipal,Nicole S. Verkaik,Najim Ameziane,Carolien H. M. van Deurzen,Petra ter Brugge,Matty Meijers,Anieta M. Sieuwerts,John W.M. Martens,Mark J. O’Connor,Harry Vrieling,Jan H.J. Hoeijmakers,Jos Jonkers,Roland Kanaar,Johan P. de Winter,Maaike P.G. Vreeswijk,Agnes Jager,Dik C. van Gent	2014	124
15	Functional Assays for Analysis of Variants of Uncertain Significance inBRCA2 Human Mutation ·Lucia Guidugli,Aura Carreira,Sandrine M. Caputo,Åsa Ehlén,Alvaro Galli,Álvaro N.A. Monteiro,Susan L. Neuhausen,Thomas van Overeem Hansen,Fergus J. Couch,Maaike P.G. Vreeswijk	2013	82
16	A guide for functional analysis ofBRCA1variants of uncertain significance Human Mutation ·Gaël A. Millot,Marcelo A. Carvalho,Sandrine M. Caputo,Maaike P.G. Vreeswijk,Melissa A. Brown,Michelle Webb,Étienne Rouleau,Susan L. Neuhausen,Thomas van Overeem Hansen,Alvaro Galli,Rita D. Brandão,Marinus J. Blok,Aneliya Velkova,Fergus J. Couch,Álvaro N.A. Monteiro	2012	82
17	Analysis and Interpretation of RNA Splicing Alterations in Genes Involved in Genetic Disorders Methods in molecular biology ·Maaike P.G. Vreeswijk,Heleen M. van der Klift	2012	11
18	Site-specific analysis of UV-induced cyclobutane pyrimidine dimers in nucleotide excision repair-proficient and -deficient hamster cells: Lack of correlation with mutational spectra Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Maaike P.G. Vreeswijk,Caro M. Meijers,Micheline Giphart-Gassler,Harry Vrieling,A.A. van Zeeland,Leon H.F. Mullenders,Wil A. M. Loenen	2008	4
19	Intronic variants inBRCA1andBRCA2that affect RNA splicing can be reliably selected by splice-site prediction programs Human Mutation ·Maaike P.G. Vreeswijk,Jaco Kraan,Heleen M. van der Klift,Geraldine R. Vink,Cees J. Cornelisse,Juul Wijnen,Egbert Bakker,Christi J. van Asperen,Peter Devilee	2008	68
20	Deficient global genome repair of UV-induced cyclobutane pyrimidine dimers in terminally differentiated myocytes and proliferating fibroblasts from the rat heart DNA repair ·Caroline Geertruida Christina van der Wees,Maaike P.G. Vreeswijk,Marion Persoon,Arnoud van der Laarse,A.A. van Zeeland,Leon H.F. Mullenders	2003	19

About Maaike P.G. Vreeswijk

Maaike P.G. Vreeswijk is a scholar working on Genetics, Cancer Research and Reproductive Medicine, having authored 50 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (25 papers), BRCA gene mutations in cancer (25 papers), CRISPR and Genetic Engineering (17 papers), PARP inhibition in cancer therapy (12 papers), Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (7 papers), Genomics and Rare Diseases (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). The work is most often cited by research in Cancer Research (363 citations), Genetics (649 citations) and Reproductive Medicine (189 citations). Maaike P.G. Vreeswijk has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Harry Vrieling, Peter Devilee, Christi J. van Asperen, Jan H.J. Hoeijmakers, A.A. van Zeeland, Dik C. van Gent, Carolien H. M. van Deurzen, Roland Kanaar, Marthe M. de Jonge and Kishan A.T. Naipal. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact